Pacific biosciences of california stock.

See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.US Stock MarketDetailed Quotes. PACB Pacific Biosciences of California. Close 11/13 16:00 ET. 6.440. -0.080 -1.23%. High 6.525. Low 6.175. Volume4.80M. Post ...Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...Nov 21, 2023 · HENRY CHRISTIAN O, the of Pacific Biosciences of California Inc, sale 96,844 shares at $10.12 during a trade that took place back on Sep 18, which means that HENRY CHRISTIAN O is holding 1,106,095 shares at $980,255 based on the most recent closing price. Stock Fundamentals for PACB. Current profitability levels for the company are sitting at:

See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

The entire state of California is located within the Pacific time zone. As of 2014, the state observes Pacific Standard Time between the middle of the fall and the end of the winter. At all other times, Pacific Daylight Time is observed.And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...

Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase.Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock. The opinion of analysts covering the stock has improved over the past four months.PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...

Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...

Pacific Biosciences of California, Inc. has a twelve month low of $5.74 and a twelve month high of $14.55. The stock has a market cap of $2.37 billion, a P/E ratio of -6.99 and a beta of 1.78. The ...

Traveling by car offers a sense of freedom and adventure that is hard to replicate with other modes of transportation. The Pacific Coast Highway, also known as Highway 1, stretches for over 600 miles along the stunning coastline of Californ...Management will host a quarterly conference call to discuss its first quarter ended March 31, 2022, results today at 5:00 p.m. Eastern Time. Investors may listen to the call by dialing 866-652-5200, or if outside the U.S., by dialing 412-317-6060, and request to join the “PacBio Q1 Earnings Call.”. The call will be webcast live and will be ...Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'...PACB Employees of TheStreet are prohibited from trading individual securities. These recently downgraded names are displaying both quantitative and technica...Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, balance sheet, cash flow, and market cap for the second quarter of 2023.According to 6 analyst offering 12-month price targets in the last 3 months, Pacific Biosciences has an average price target of $14.67 with a high of $17.00 and a low of $12.00. Below is a summary ...

The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …Stock Quote. NASDAQ; PACB: Price; $8.88: Change; +0.4: Change(%); +4.72%: Volume; 4,099,397: 52 ... Pacific Biosciences of California, Inc. Third Quarter 2023 ...٢٥‏/٠٩‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 5.37% ... Avoid the stress of overpaying for a stock or missing an opportunity by ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

Nov 30, 2023 · PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes. Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …

Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Email Alerts The Investor Relations website contains information …Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq News. PacBio Announces …STOCK INFORMATION IRS Notification. Form 8937 Omniome. Stock Quote ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025Common Stock, par value $0.001 per share. PACB. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, …Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter ...Get the latest Pacific Biosciences of California Inc (P09) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...٠٣‏/٠٤‏/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.

Pacific Biosciences of California Stock Earnings. The value each PACB share was expected to gain vs. the value that each PACB share actually gained. PACB ( PACB) reported Q3 2023 earnings per share (EPS) of -$0.26, beating estimates of -$0.29 by 9.37%. In the same quarter last year, PACB 's earnings per share (EPS) was -$0.34.

April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...

Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ...Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44, your return over the last 13 years would have been -47.99%, for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Pacific Biosciences of California Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 8:00 a.m. EST Delayed quote $ 8.44 0.00 0.00% Before Hours Volume: 1 Advanced...Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock. The opinion of analysts covering the stock has improved over the past four months.Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.

Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.٢٥‏/٠٩‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 5.37% ... Avoid the stress of overpaying for a stock or missing an opportunity by ...In other news concerning Pacific Biosciences of California, insider Michele Farmer sold 5,165 shares of the company’s stock on May 18th at an average price of $12.59 per share, resulting in a total transaction value of $65,027.35. Following this sale, Farmer now holds 107,577 shares of PACB stock with an approximate value of $1,354,394.43.Instagram:https://instagram. agg stocksfinancial advisor fort wayne indianasmart asset reviewsyta stocks Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.The share float percentage for the stock currently stands at 98.68%. There are 96.98% institutions holding the Pacific Biosciences of California Inc stock share, with ARK Investment Management, LLC the top institutional holder. As of Sep 29, 2023, the company held 11.15% of the shares, roughly 29.82 million PACB shares worth $247.68 … t rowe price dividend growth fundbest day trading stock alerts Apr 21, 2023 · Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ... Pacific Biosciences of California (NASDAQ:PACB) and Olink Holding AB (publ) are both mid-cap medical companies, but which is the superior business?We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. pr stock forecast Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from ...Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ...